Binding of deamidated Cltx and derived peptides increased uptake of cryptophycin metabolite into tumors; these findings are in accord with reports that NRP1 binding increases tumor uptake of a wide variety of anticancer drugs from small molecules to larger biologicals [16]. The gene discussed is NRP1; the disease is neoplasm.